Long-term Safety Study of QGE031 in Patients With Allergic Asthma Who Completed Study CQGE031B2201

Stopped early · Phase 2

Conditions studied: Asthma

In brief

This study planned to assess long-term safety of QGE031 during 12 months treatment in asthma patients who completed study CQGE031B2201.

Key facts

Study ID
NCT02075008
Run by
Novartis Pharmaceuticals
People needed
270
Starts
2014-03-27
Expected to finish
2016-03-22
Last updated by the study team
2017-08-11

Who can join

Age: 18 and older, up to 76. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.